Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4161710
Max Phase: Preclinical
Molecular Formula: C52H64N8O5
Molecular Weight: 881.13
Molecule Type: Small molecule
Associated Items:
ID: ALA4161710
Max Phase: Preclinical
Molecular Formula: C52H64N8O5
Molecular Weight: 881.13
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(N)=O)c2ccccc21
Standard InChI: InChI=1S/C52H64N8O5/c1-5-6-17-26-60-33-38(40-23-14-16-25-47(40)60)31-46(51(64)56-42(48(53)61)27-34(2)3)59-50(63)44(29-36-20-11-8-12-21-36)57-52(65)45(30-37-32-55-41-24-15-13-22-39(37)41)58-49(62)43(54-4)28-35-18-9-7-10-19-35/h7-16,18-25,32-34,42-46,54-55H,5-6,17,26-31H2,1-4H3,(H2,53,61)(H,56,64)(H,57,65)(H,58,62)(H,59,63)/t42-,43+,44-,45+,46+/m0/s1
Standard InChI Key: DYDHKJRCNOKLSO-PIDMDYRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 881.13 | Molecular Weight (Monoisotopic): 880.5000 | AlogP: 5.64 | #Rotatable Bonds: 24 |
Polar Surface Area: 192.24 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 11.93 | CX Basic pKa: 8.34 | CX LogP: 6.97 | CX LogD: 5.98 |
Aromatic Rings: 6 | Heavy Atoms: 65 | QED Weighted: 0.04 | Np Likeness Score: -0.17 |
1. Haitham Abusara O, Freeman S, Aojula HS.. (2017) Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain., 137 [PMID:28595067] [10.1016/j.ejmech.2017.05.053] |
Source(1):